Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

Overview of attention for article published in Breast Cancer Research, March 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 7 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 140 Dimensions

Readers on

mendeley: 108 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 140 publications that cite this research output.

140

The most recent citing publications are shown below. View all 140 publications that cite this research output on Dimensions.

Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs

Article in Scientific Reports (April 2024)

Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound

Article in ACS Pharmacology & Translational Science (April 2024)

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer

Article in Cell Death & Disease (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.